Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 48,300 shares, a growth of 11,975.0% from the September 30th total of 400 shares. Based on an average trading volume of 1,450,400 shares, the days-to-cover ratio is presently 0.0 days.
Oncotelic Therapeutics Price Performance
OTLC opened at $0.04 on Friday. Oncotelic Therapeutics has a fifty-two week low of $0.02 and a fifty-two week high of $0.05. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.01 and a quick ratio of 0.01. The company’s 50 day moving average price is $0.02 and its two-hundred day moving average price is $0.03.
About Oncotelic Therapeutics
See Also
- Five stocks we like better than Oncotelic Therapeutics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Texas Roadhouse Stock Steering for New Highs This Year
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Investing In Preferred Stock vs. Common Stock
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Oncotelic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncotelic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.